Land: India
Taal: Engels
Bron: Central Drugs Standard Control Organization
Mifepristone, Misoprostol
Cadila Pharma
mifopristone 200mg, misoprostol 200 μg
Tablet
1 tablet of mifepristone 200, 4 tablets of misoprostol 200 mcg
Oral
1 KIT (1+4)
Hormones, Contraceptives and Related Drugs
Medical termination of pregnancy of up to 49 days, cervical dilatation prior to surgical termination of pregnancy in the first trimester, therapeutic termination of pregnancy for medical reasons beyond the first trimester, labor induction in case of fetal death in utero.
MIFEPRISTONE + MISOPROSTOL Pregnancy Category-X Schedule H INDICATIONS Medical termination of pregnancy of up to 49 days, cervical dilatation prior to surgical termination of pregnancy in the first trimester, therapeutic termination of pregnancy for medical reasons beyond the first trimester, labor induction in case of fetal death in utero. AVAILABILITY Tablet KIT mifopristone 200mg, misoprostol 200 μg. DOSE Mifepristone 200 mg orally followed 1 to 3 days latter by misoprostol 800 μg vaginally. Patients should return for follow up visit after approximately 14 days after administration of mifepristone. CONTRAINDICATIONS Hypersensitivity to Mifepristone, Misoprostol or other prostaglandin; confirmed or suspected ectopic pregnancy; chronic adrenal failure; haemorrhagic disorders or concurrent anticoagulant therapy; inherited porphyria. PRECAUTIONS IUD in place; asthma, chronic obstructive pulmonary disease; alcoholism; prosthetic heart valve; infective endocarditis;, pregnancy. ADVERSE EFFECTS Abdominal pain, diarrhoea, nausea, vomiting; fever, chills, uterine cramping; vaginal bleeding or spotting; Pelvic inflammatory disease. INTERACTIONS Dexamethasone: decreased serum levels of mifepristone ------------------------- DOCUMENT OUTLINE * Mifepristone + Misoprostol [/In_18294_SPC.html#1] * Indications [/In_18294_SPC.html#1] * Availability [/In_18294_SPC.html#1] * Dose [/In_18294_SPC.html#1] * Contraindications [/In_18294_SPC.html#1] * Precautions [/In_18294_SPC.html#1] * Adverse Effects [/In_18294_SPC.html#1] * Interactions [/In_18294_SPC.html#1] Lees het volledige document